Protective effects of gastrin‐releasing peptide receptor antagonist RC‐3095 in an animal model of hepatic ischemia/reperfusion injury

2019 ◽  
Vol 49 (3) ◽  
pp. 247-255 ◽  
Author(s):  
Long Guo ◽  
Xinwan Wu ◽  
Ying Zhang ◽  
Fang Wang ◽  
Jinbao Li ◽  
...  
2013 ◽  
Vol 43 ◽  
pp. 592-598
Author(s):  
Ayca TAŞ TUNA ◽  
Cengiz Bekir DEMİREL ◽  
Yusuf ÜNAL ◽  
Aslıhan ÇAVUNT BAYRAKTAR ◽  
Demet YILMAZER ◽  
...  

PPAR Research ◽  
2021 ◽  
Vol 2021 ◽  
pp. 1-16
Author(s):  
Jie Zhang ◽  
Ping Cheng ◽  
Weiqi Dai ◽  
Jie Ji ◽  
Liwei Wu ◽  
...  

Hepatic ischemia and reperfusion injury is characterized by hepatocyte apoptosis, impaired autophagy, and oxidative stress. Fenofibrate, a commonly used antilipidemic drug, has been verified to exert hepatic protective effects in other cells and animal models. The purpose of this study was to identify the function of fenofibrate on mouse hepatic IR injury and discuss the possible mechanisms. A segmental (70%) hepatic warm ischemia model was established in Balb/c mice. Serum and liver tissue samples were collected for detecting pathological changes at 2, 8, and 24 h after reperfusion, while fenofibrate (50 mg/kg, 100 mg/kg) was injected intraperitoneally 1 hour prior to surgery. Compared to the IR group, pretreatment of FF could reduce the inflammatory response and inhibit apoptosis and autophagy. Furthermore, fenofibrate can activate PPAR-α, which is associated with the phosphorylation of AMPK.


2018 ◽  
Vol 34 (3) ◽  
pp. 198-204 ◽  
Author(s):  
Suleyman Atalay ◽  
◽  
Belkis Soylu ◽  
Asli Aykac ◽  
Ayliz Velioglu Ogunc ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document